President Trump did not sign an executive order for de facto marijuana legalization as hoped, causing a 10% drop in Tilray Brands (NASDAQ: TLRY) stock. The DEA currently classifies marijuana as Schedule I, but rescheduling could move it to Schedule III, lowering restrictions. Investors eagerly sold out of Tilray on Monday, anticipating the EO’s imminent signing.

The market won’t be comfortable with cannabis stocks until rescheduling occurs. Weed companies face financial service obstacles due to marijuana’s legal status. It’s best not to trade based on speculation; wait for Trump to sign the actual EO before investing in pot stocks. Some states have legalized marijuana, but federal laws remain restrictive.

Consider the potential risks before buying Tilray Brands stock. The Motley Fool Stock Advisor team has identified 10 better stocks for investors to buy now, excluding Tilray Brands. Stock Advisor’s top 10 list has historically outperformed the S&P 500, offering substantial returns. Don’t miss the latest list for investment opportunities.

The Motley Fool’s Eric Volkman has no position in Tilray Brands but recommends the stock. Tilray stock plummeted on Monday due to Trump’s failure to sign the expected EO. Stay informed about marijuana legalization news and stock movements for potential investment opportunities.

Read more at Yahoo Finance: Why Tilray Stock Plunged Today